8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Involvement of Osteocytes in the Action of Pasteurella multocida Toxin

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Pasteurella multocida toxin (PMT) causes progressive atrophic rhinitis with severe turbinate bone degradation in pigs. It has been reported that the toxin deamidates and activates heterotrimeric G proteins, resulting in increased differentiation of osteoclasts and blockade of osteoblast differentiation. So far, the action of PMT on osteocytes, which is the most abundant cell type in bone tissue, is not known. In MLO-Y4 osteocytes, PMT deamidated heterotrimeric G proteins, resulting in loss of osteocyte dendritic processes, stress fiber formation, cell spreading and activation of RhoC but not of RhoA. Moreover, the toxin caused processing of membrane-bound receptor activator of NF-κB ligand (RANKL) to release soluble RANKL and enhanced the secretion of osteoclastogenic TNF-α. In a co-culture model of osteocytes and bone marrow cells, PMT-induced osteoclastogenesis was largely increased as compared to the mono-culture model. The enhancement of osteoclastogenesis observed in the co-culture was blocked by sequestering RANKL with osteoprotegerin and by an antibody against TNF-α indicating involvement of release of the osteoclastogenic factors from osteocytes. Data support the crucial role of osteocytes in bone metabolism and osteoclastogenesis and identify osteocytes as important target cells of PMT in progressive atrophic rhinitis.

          Related collections

          Most cited references36

          • Record: found
          • Abstract: not found
          • Article: not found

          Bone remodelling at a glance.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts.

            Osteoclast progenitors differentiate into mature osteoclasts in the presence of receptor activator of NF-kappaB (RANK) ligand on stromal or osteoblastic cells and monocyte macrophage colony-stimulating factor (M-CSF). The soluble RANK ligand induces the same differentiation in vitro without stromal cells. Tumor necrosis factor-alpha (TNF-alpha), a potent cytokine involved in the regulation of osteoclast activity, promotes bone resorption via a primary effect on osteoblasts; however, it remains unclear whether TNF-alpha can also directly induce the differentiation of osteoclast progenitors into mature osteoclasts. This study revealed that TNF-alpha directly induced the formation of tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells (MNCs), which produced resorption pits on bone in vitro in the presence of M-CSF. The bone resorption activity of TNF-alpha-induced MNCs was lower than that of soluble RANK ligand-induced MNCs; however, interleukin-1beta stimulated this activity of TNF-alpha-induced MNCs without an increase in the number of MNCs. In this case, interleukin-1beta did not induce TRAP-positive MNC formation. The osteoclast progenitors expressed TNF receptors, p55 and p75; and the induction of TRAP-positive MNCs by TNF-alpha was inhibited completely by an anti-p55 antibody and partially by an anti-p75 antibody. Our findings presented here are the first to indicate that TNF-alpha is a crucial differentiation factor for osteoclasts. Our results suggest that TNF-alpha and M-CSF play an important role in local osteolysis in chronic inflammatory diseases.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              New insights into osteoclastogenic signaling mechanisms.

              Bone is continuously renewed through a dynamic balance between bone resorption and formation. This process is the fundamental basis for the maintenance of normal bone mass and architecture. Osteoclasts play a crucial role in both physiological and pathological bone resorption, and receptor activator of nuclear factor-κB ligand (RANKL) is the key cytokine that induces osteoclastogenesis. Here we summarize the recent advances in the understanding of osteoclastogenic signaling by focusing on the investigation of RANKL signaling and RANKL-expressing cells in the context of osteoimmunology. The context afforded by osteoimmunology will provide a scientific basis for future therapeutic approaches to diseases related to the skeletal and immune systems. Copyright © 2012 Elsevier Ltd. All rights reserved.
                Bookmark

                Author and article information

                Journal
                Toxins (Basel)
                Toxins (Basel)
                toxins
                Toxins
                MDPI
                2072-6651
                13 August 2018
                August 2018
                : 10
                : 8
                : 328
                Affiliations
                [1 ]Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Medizinische Fakultät, Albert-Ludwigs-Universität Freiburg, Albertstr. 25, 79104 Freiburg, Germany; hannah.heni@ 123456pharmakol.uni-freiburg.de (H.H.); julia.behr@ 123456pharmakol.uni-freiburg.de (J.K.E.); gudula.schmidt@ 123456pharmakol.uni-freiburg.de (G.S.); joachim.orth@ 123456pharmakol.uni-freiburg.de (J.H.C.O.)
                [2 ]Hermann-Staudinger-Graduiertenschule, Universität Freiburg, 79104 Freiburg, Germany
                [3 ]Spemann Graduate School of Biology and Medicine (SGBM), Universität Freiburg, 79104 Freiburg, Germany
                [4 ]Faculty of Biology, Universität Freiburg, 79104 Freiburg, Germany
                [5 ]BIOSS Centre for Biological Signalling Studies, Universität Freiburg, 79104 Freiburg, Germany
                Author notes
                [* ]Correspondence: klaus.aktories@ 123456pharmakol.uni-freiburg.de ; Tel.: +49-761-2035301
                Author information
                https://orcid.org/0000-0002-2876-0189
                https://orcid.org/0000-0002-5397-0436
                Article
                toxins-10-00328
                10.3390/toxins10080328
                6115833
                30104531
                b1e15689-d1c5-4708-b73a-6104d666f880
                © 2018 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 25 July 2018
                : 08 August 2018
                Categories
                Article

                Molecular medicine
                pasteurella multocida toxin (pmt),deamidation,osteocytes,osteoclastogenesis
                Molecular medicine
                pasteurella multocida toxin (pmt), deamidation, osteocytes, osteoclastogenesis

                Comments

                Comment on this article